Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
13F holders, Q1 2025
Institutional positions in Biofrontera Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −2 vs. Q4 2024
- Shares held
- 1.48M
- −329.3K (−18.2%) vs. Q4 2024
- Total value
- $1.18M
- −$787.8K (−39.9%) vs. Q4 2024
- New holders
- 3
- 3 more added
- Sold out
- 5
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BFRI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $2.61M |
| Q1 2026 | 12 | $1.94M |
| Q4 2025 | 14 | $1.33M |
| Q3 2025 | 13 | $2.39M |
| Q2 2025 | 10 | $1.45M |
| Q1 2025 | 12 | $1.18M |
| Q4 2024 | 14 | $1.97M |
| Q3 2024 | 9 | $1.43M |
| Q2 2024 | 12 | $1.05M |
| Q1 2024 | 11 | $1.67M |
| Q4 2023 | 8 | $26.2K |
| Q3 2023 | 8 | $142.2K |
| Q2 2023 | 13 | $412.7K |
| Q1 2023 | 16 | $517.9K |
| Q4 2022 | 14 | $729.4K |
| Q3 2022 | 16 | $900.0K |
| Q2 2022 | 15 | $3.01M |
| Q1 2022 | 12 | $2.66M |
| Q4 2021 | 15 | $5.29M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Biofrontera Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 732,155 | $585.7K | 0.30% | −78,942−9.7% | Reduced |
| Rosalind Advisors, Inc. | 644,393 | $515.5K | 0.25% | −167,525−20.6% | Reduced |
| Geode Capital Management, LLC | 40,144 | $32.1K | 0.00% | +20,840+108.0% | Added |
| Citadel Advisors LLC | 28,224 | $22.6K | 0.00% | +28,224 | New |
| Virtu Financial LLC | 18,479 | $15.0K | 0.00% | −25,627−58.1% | Reduced |
| Two Sigma Securities, LLC | 11,253 | $9.00K | 0.00% | −6,803−37.7% | Reduced |
| BlackRock, Inc. | 4,622 | $3.70K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 309 | $247 | 0.00% | +3+1.0% | Added |
| JPMorgan Chase & Co | 197 | $158 | 0.00% | +197 | New |
| Morgan Stanley | 160 | $128 | 0.00% | +160 | New |
| Bank of America Corp | 43 | $34 | 0.00% | +1+2.4% | Added |
| UBS Group AG | 31 | $25 | 0.00% | −14,042−99.8% | Reduced |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −45,558−100.0% | Sold out |
| Scotia Capital Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,095−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,539−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −576−100.0% | Sold out |